Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02605785 · ClinicalTrials.gov registry record · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
A NA study of Progressive Supranuclear Palsy, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 1
- Study location
NCT02605785: Recruiting NA study of Progressive Supranuclear Palsy, sponsored by Mayo Clinic.
NCT02605785 is a NA study of Progressive Supranuclear Palsy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 332 participants, below the 434-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02605785, a NA study of Progressive Supranuclear Palsy, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).
Conditions Studied
Interventions
- DRUG F-18 AV 1451
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2015-11 |
| Est. Completion | 2030-01 |
| Phase | NA |
What NCT02605785 shows while recruiting
NCT02605785 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 434-participant average among 18 other Progressive Supranuclear Palsy trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Progressive Supranuclear Palsy appearing as the primary indexed condition, and to 1 intervention - of which F-18 AV 1451 is the first listed.
NCT02605785 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02605785 about?
NCT02605785 is a clinical study titled "A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy". This study is designed to learn more about overall tau burden in the brain of patients with Progressive Supranuclear Palsy (PSP).
What is the current status of trial NCT02605785?
This trial is currently recruiting. It is a NA study. The enrollment target is 332 participants. The study started on 2015-11. Estimated completion is 2030-01.
What conditions does trial NCT02605785 study?
This clinical trial studies the following conditions: Progressive Supranuclear Palsy.
What interventions are being tested in trial NCT02605785?
The interventions under investigation include: F-18 AV 1451 (DRUG).
Who is sponsoring clinical trial NCT02605785?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02605785 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Progressive Supranuclear Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02605785's enrollment target sits among peer trials
332 6th of 18 higher than 13 of 18 other Progressive Supranuclear Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Progressive Supranuclear Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Art Therapy in Progressive Supranuclear Palsy
ACTIVE NOT RECRUITING · NA
-
Community Outreach for Palliative Engagement -- Parkinson Disease
ACTIVE NOT RECRUITING · NA
-
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
ACTIVE NOT RECRUITING · NA
-
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
COMPLETED · NA
-
In-Home Care for Patients With PSP and Related Disorders
COMPLETED · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- NCT05320588 · 332 participants · Phase 1
A Study in Patients With Advanced Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia